Aktuell (Grundlagenforschung)
- ALK gene status and protein expression in gastroesophageal adenocarcinomas and squamous cell carcinoma of the esophagus
- Clinical role of peripheral blood platelets in angiogenesis and lymphangiogenesis of esophageal cancer
- Evaluation of established prognostic factors as predictive factors for histological and PET-CT assessed response to neoadjuvant chemotherapy in esophageal cancer
- Molecular profiling of brain metastases in gastroesophageal cancer
- MAPKAP Kinase 2 and ETV-1 in esophageal cancer and its metastases
- Next generation exom sequencing of gastrointestinal stromal tumors (Cooperation University of Heidelberg)
- MicroRNA profiling in esophageal adenocarcinoma and Barrett´s esopahgus
- Role of MEK1/MEK2 and RAF-kinase inhibitory protein in GIST
Interdisziplinäre und inter-/nationale Kooperationen
- ASSO (Austrian Society of Surgical Oncology)
- NIH/NCI (Division of Cancer Epidemiology and Genetics, Bethesta)
- Universität Heidelberg
- T. Helbich, Small Animal Imaging Unit, Medizinische Universität Wien
Zukünftig (Grundlagenforschung)
- Role of PTEN/PI3K/AKT pathway -activation on neoangiogenesis and cell migration in esophageal cancer
- Influence of JAK1/JAK2 on phosphorylation of STAT3 in esophagel cancer
- MicroRNA profiling in esophageal adenocarcinoma and Barrett´s esopahgus
- Next generation sequencing for detection of clonal evolution of gastro-oesphageal cancer cells during neodjuvant chemotherapy
- Inhibition of ER81/MAPKAPK2 pathway in GIST cell lines
- Ultra deep sequencing for detection of minimal residual disease in gastroesophageal tumors
- Crizotinib for inhibition of ALK amplificated Upper GI cell lines in vitro
- HPV status in relation to p16 expression oesophageal cancer
- Her-Ligands and their interaction with ERBB1 and HER2 in gastro-oesophageal cancer